SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401914-23-000007
Filing Date
2023-01-26
Accepted
2023-01-26 16:06:19
Documents
1
Period of Report
2023-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167476716272724.html 4  
1 FORM 4 wf-form4_167476716272724.xml 4 3944
  Complete submission text file 0001401914-23-000007.txt   5553
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Walters-Hoffert Lisa (Reporting) CIK: 0001711576 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 23557730